Name | Title | Contact Details |
---|---|---|
Joseph Lentini |
Executive Director, Specialty Sales | Profile |
Terry VanEpps |
Director Talent Acquisition | Profile |
Jim Blay |
Associate Director, IT Business Partner, R&D | Profile |
Troy Lister |
Senior Vice President Research Development | Profile |
Esther Rajavelu |
Chief Financial Officer and Chief Business Officer | Profile |
Previously Mr. Lerner has served as Vice President of Engineering and Technology for both Image Sensing Systems, Inc. and Telex Communications, Inc.
IsoPlexis is leading a new era of functional proteomics. By identifying our most proteomically active single cells (or "superhero cells") for the first time, IsoPlexis enables researchers to connect more directly to in vivo biology and develop more precise and personalized therapies. IsoPlexis has been named Top Innovation or Design by The Scientist Magazine, Fierce, BIG Innovation, Red Dot and multiple others. The IsoPlexis platform is used globally by researchers, including those at the top 15 global pharmaceutical companies and at the majority of leading U.S. comprehensive cancer centers.
Applied Therapeutics is a clinical-stage biopharmaceutical company that uses our novel drug-development approach to create transformative, life-changing treatments for the patients who desperately need them.
MB Research Laboratories is a Spinnerstown, PA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Concuity is a Vernon Hills, IL-based company in the Healthcare, Pharmaceuticals, & Biotech sector.